Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Zeghari

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Lipids|July 27, 1999
Adipose peroxisome proliferator-activated receptor gamma mRNA expression in insulin-resistant obese patients: relationship with adipocyte membrane phospholipidsN Zeghari, H Vidal, S Perche, et al.
Photochemistry and Photobiology|August 1, 1996
Spectroscopic and biological testing of photobleaching of porphyrins in solutionsL Bezdetnaya, N Zeghari, I Belitchenko, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 15, 2012
[Recommendation of the working group commissioned by the French Nuclear Safety Authority on stereotactic radiation therapy]J-P Gérard, B Aubert, I Buchheit, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Lipids|July 27, 1999
Adipose peroxisome proliferator-activated receptor gamma mRNA expression in insulin-resistant obese patients: relationship with adipocyte membrane phospholipidsN Zeghari, H Vidal, S Perche, et al.
Photochemistry and Photobiology|August 1, 1996
Spectroscopic and biological testing of photobleaching of porphyrins in solutionsL Bezdetnaya, N Zeghari, I Belitchenko, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 15, 2012
[Recommendation of the working group commissioned by the French Nuclear Safety Authority on stereotactic radiation therapy]J-P Gérard, B Aubert, I Buchheit, et al.
Pageof 2